JPS56150090A - Novel imidazopyridine comopounds, their manufacture and cardiac stimulant thereof - Google Patents

Novel imidazopyridine comopounds, their manufacture and cardiac stimulant thereof

Info

Publication number
JPS56150090A
JPS56150090A JP4533681A JP4533681A JPS56150090A JP S56150090 A JPS56150090 A JP S56150090A JP 4533681 A JP4533681 A JP 4533681A JP 4533681 A JP4533681 A JP 4533681A JP S56150090 A JPS56150090 A JP S56150090A
Authority
JP
Japan
Prior art keywords
comopounds
manufacture
cardiac stimulant
novel imidazopyridine
imidazopyridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP4533681A
Other languages
English (en)
Japanese (ja)
Inventor
Yoofu Retsushiyaa Jiyooji
Jiyosefu Oparuka Jiy Chiesutaa
Furederitsuku Peeji Donarudo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
STWB Inc
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug Inc filed Critical Sterling Drug Inc
Publication of JPS56150090A publication Critical patent/JPS56150090A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/76—Nitrogen atoms to which a second hetero atom is attached
    • C07D213/77—Hydrazine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP4533681A 1980-03-28 1981-03-27 Novel imidazopyridine comopounds, their manufacture and cardiac stimulant thereof Pending JPS56150090A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/135,211 US4276293A (en) 1980-03-28 1980-03-28 Compositions and their preparation

Publications (1)

Publication Number Publication Date
JPS56150090A true JPS56150090A (en) 1981-11-20

Family

ID=22467044

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4533681A Pending JPS56150090A (en) 1980-03-28 1981-03-27 Novel imidazopyridine comopounds, their manufacture and cardiac stimulant thereof

Country Status (22)

Country Link
US (1) US4276293A (cg-RX-API-DMAC7.html)
JP (1) JPS56150090A (cg-RX-API-DMAC7.html)
KR (1) KR830005217A (cg-RX-API-DMAC7.html)
AU (1) AU6883781A (cg-RX-API-DMAC7.html)
BE (1) BE888088A (cg-RX-API-DMAC7.html)
CA (1) CA1159061A (cg-RX-API-DMAC7.html)
DE (1) DE3112197A1 (cg-RX-API-DMAC7.html)
DK (1) DK136881A (cg-RX-API-DMAC7.html)
ES (1) ES500727A0 (cg-RX-API-DMAC7.html)
FI (1) FI810921L (cg-RX-API-DMAC7.html)
FR (1) FR2479225A1 (cg-RX-API-DMAC7.html)
GB (1) GB2072673B (cg-RX-API-DMAC7.html)
IL (1) IL62403A0 (cg-RX-API-DMAC7.html)
IT (1) IT1136972B (cg-RX-API-DMAC7.html)
LU (1) LU83259A1 (cg-RX-API-DMAC7.html)
NL (1) NL8101455A (cg-RX-API-DMAC7.html)
NO (1) NO811041L (cg-RX-API-DMAC7.html)
NZ (1) NZ196573A (cg-RX-API-DMAC7.html)
PH (1) PH16999A (cg-RX-API-DMAC7.html)
PT (1) PT72744B (cg-RX-API-DMAC7.html)
SE (1) SE8101951L (cg-RX-API-DMAC7.html)
ZA (1) ZA811776B (cg-RX-API-DMAC7.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4363911A (en) * 1981-09-03 1982-12-14 Sterling Drug Inc. 1,2-Dihydro-6-[2-(dimethylamino)ethenyl]-2-oxo-5-(pyridinyl) nicotinonitriles
US4465686A (en) * 1981-09-08 1984-08-14 Sterling Drug Inc. 5-(Hydroxy- and/or amino-phenyl)-6-(lower-alkyl)-2-(1H)-pyridinones, their cardiotonic use and preparation
US4347363A (en) * 1981-09-17 1982-08-31 Sterling Drug Inc. Process for preparing 1,2-dihydro-6-methyl-2-oxo-5-(pyridinyl)nicotinonitriles
US4599423A (en) * 1982-04-26 1986-07-08 Sterling Drug Inc. Preparation of 5-(hydroxy- and/or aminophenyl-6-lower-alkyl)-2(1H)-pyridinones
US4417054A (en) * 1982-05-24 1983-11-22 Sterling Drug Inc. 2-(Lower-alkoxy)-1-(pyridinyl)ethenyl lower-alkyl ketones
NO163008C (no) * 1982-05-24 1990-03-21 Sterling Drug Inc 2-(laverealkoksy)-1-(pyridinyl)etenyl-lavere-alkylketon og fremgangsmaate for fremstilling av pyridinylnikotinderivater.
US4413127A (en) * 1982-05-24 1983-11-01 Sterling Drug Inc. Preparation of 1,2-dihydro-6-(lower alkyl)-2-oxo-5-(pyridinyl)nicotinonitriles
US4469871A (en) * 1982-05-24 1984-09-04 Sterling Drug Inc. Process for preparing 2-(lower-alkoxy)-1-(pyridinyl) ethenyl lower-alkyl ketones
US4469699A (en) * 1982-08-25 1984-09-04 Sterling Drug Inc. 5-(4-Thiazolyl)-6-alkyl-2(1H)-pyridinones and their cardiotonic use
US4595762A (en) * 1982-08-25 1986-06-17 Sterling Drug Inc. 5-α-bromoalkanoyl-2-oxo-3-pyridinecarbonitriles
US4539327A (en) * 1982-08-25 1985-09-03 Sterling Drug Inc. 5-(2-Substituted-4-thiazolyl)-6-alkyl-2(1H)-pyridinones and cardiotonic use thereof
US4448780A (en) * 1982-09-03 1984-05-15 Sterling Drug Inc. N-(Lower-alkyl)-N'-[5-(pyridinyl)-2-pyridinyl]ureas and cardiotonic use thereof
US4517192A (en) * 1983-01-31 1985-05-14 Sterling Drug Inc. 6-Alkyl-5-[4-(alkylsulfinyl or alkylsulfonyl)phenyl]-2(1H)-pyridinones and their use as cardiatonics
AU3820989A (en) * 1988-08-02 1990-02-08 Ciba-Geigy Ag 7-amino-3-beta-d-ribofuranosyl-3h-imidazo(4,5-b) pyridin-5-amine derivatives
US4977144A (en) * 1988-08-02 1990-12-11 Ciba-Geigy Corporation Imidazo[4,5-b]pyridine derivatives as cardiovascular agents
US5010086A (en) * 1990-02-28 1991-04-23 Sterling Drug Inc. Imidazopyridines, compositions and use
US4963561A (en) * 1990-02-28 1990-10-16 Sterling Drug Inc. Imidazopyridines, their preparation and use
US6465484B1 (en) * 1997-09-26 2002-10-15 Merck & Co., Inc. Angiogenesis inhibitors
US20050112770A1 (en) 2002-02-14 2005-05-26 Fuji Photo Film Co., Ltd. Method for optical measurement of multi-stranded nucleic acid

Also Published As

Publication number Publication date
ES8202343A1 (es) 1982-01-16
SE8101951L (sv) 1981-09-29
NO811041L (no) 1981-09-28
IT1136972B (it) 1986-09-03
LU83259A1 (fr) 1981-10-29
FI810921A7 (fi) 1981-09-29
KR830005217A (ko) 1983-08-03
GB2072673B (en) 1983-11-02
ES500727A0 (es) 1982-01-16
IT8120784A0 (it) 1981-03-27
DE3112197A1 (de) 1982-02-25
PT72744B (en) 1982-03-24
IL62403A0 (en) 1981-05-20
GB2072673A (en) 1981-10-07
AU6883781A (en) 1981-10-08
FI810921L (fi) 1981-09-29
NZ196573A (en) 1984-03-16
ZA811776B (en) 1982-04-28
FR2479225B1 (cg-RX-API-DMAC7.html) 1984-05-18
CA1159061A (en) 1983-12-20
US4276293A (en) 1981-06-30
PH16999A (en) 1984-05-04
BE888088A (fr) 1981-09-24
NL8101455A (nl) 1981-10-16
PT72744A (en) 1981-04-01
DK136881A (da) 1981-09-29
FR2479225A1 (fr) 1981-10-02

Similar Documents

Publication Publication Date Title
JPS56150064A (en) Novel pyridine compounds, their manufacture and cardiac stimulant thereof
DE3176731D1 (en) 1-sulfo-2-oxoazetidine derivatives, their production and use
ZA812708B (en) Ss-lactam compounds, their preparation and use
JPS56150090A (en) Novel imidazopyridine comopounds, their manufacture and cardiac stimulant thereof
DE3163035D1 (en) Cyclic imides, their preparation and use
JPS56150089A (en) Novel imidazo(4,5-b)pyridine derivatives, their manufacture and cardiac stimulant thereof
JPS577823A (en) Novel zeolite,use and manufacture
JPS5716868A (en) 1-hydroxyethyl-azole derivative,manufacture and use
DE3165091D1 (en) Valienamine derivatives, their production and use
JPS57120586A (en) Dibenzazepine derivative, manufacture and use
JPS5756478A (en) Triazinylaminotriazines, manufacture and use
JPS57131744A (en) Substituted phenoxycinnamic acid derivative, manufacture and use
JPS5795971A (en) Compound, manufacture and use
JPS56142281A (en) Pyrazolopyridine derivatives, their manufacture and cardiac stimulant therefrom
DE3162556D1 (en) N-benzylphenylacetamide derivatives, their production and use
JPS57136583A (en) Novel benzimidazole compounds, manufacture and cardiac stimulant
JPS5748993A (en) N-phosphonylcarbonyl-carbamates, manufacture and use
JPS5795973A (en) Compound, manufacture and use
JPS57131796A (en) Penicillanic acid derivative, manufacture and use
JPS5711965A (en) Aminophenylpyridine cardiac stimulant
JPS57140767A (en) Novel nicotinamide derivative, manufacture and cardiac stimulant
JPS56147728A (en) Novel compound, its manufacture and use
ZA811567B (en) 2-penem-3-carboxylic acid derivatives, their preparation and use
DE3166164D1 (en) Anthraquinone-azo compounds, their preparation and their use
JPS57122077A (en) Dihydropyranes, manufacture and use